Labcorp’s Akinbolade Oyegunwa receives 370 shares

Q: How many shares did LH's EVP receive from vested RSUs?

Akinbolade Oyegunwa converted 370 vested restricted stock units into 370 common shares on November 1, 2026. The units came from a grant that vests in three equal annual installments beginning November 1, 2025.

Q: How many LH shares were withheld for taxes, and at what price?

118 common shares were withheld on November 2, 2026, at $355.59 per share to satisfy tax withholding obligations. No Rule 10b5-1 plan is reported.

The EVP, CIO & CTO's vested units came from a grant scheduled to vest in three equal annual installments beginning November 1, 2025.

Available on EDGAR 11/03/2026 - 10:16 AM EST Accepted by SEC EDGAR 11/03/2026 - 10:15 AM EST

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)How Sentiment works

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment works How the balance works

Form Type

Rhea-AI Filing Summary

Labcorp Holdings Inc. reported that Akinbolade Oyegunwa, EVP, CIO & CTO, converted 370 vested restricted stock units into 370 common shares on November 1, 2026. The units were part of a grant vesting in three equal annual installments beginning November 1, 2025; aggregate RSUs held afterward were 2,570. On November 2, 2026, 118 common shares were withheld at $355.59 per share to satisfy tax withholding obligations.

Insider Trade Summary

370 shares exercised/converted

Exercise 3 txns

Insider Oyegunwa Akinbolade

Role EVP, CIO & CTO

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock ^F2	118	$355.59	$42K
Exercise	Restricted Stock Unit ^{F1, F3, F4}	370	$0.00	$0.00
Exercise	Common Stock ^F1	370	--	--

Holdings After Transaction: Restricted Stock Unit — 2,570 contracts (Direct); Common Stock — 5,316.253 shares (Direct)

Footnotes (4)

F1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.
F2. Stock withholding to satisfy tax withholding obligations.
F3. The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on November 1, 2025.
F4. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

Key Figures

Vested restricted stock units converted: 370 restricted stock units Common shares received: 370 shares Common shares withheld for taxes: 118 shares +2 more

5 metrics

Vested restricted stock units converted 370 restricted stock units November 1, 2026

Common shares received 370 shares November 1, 2026

Common shares withheld for taxes 118 shares November 2, 2026

Price per withheld share $355.59 per share November 2, 2026

Aggregate restricted stock units held after transaction 2,570 restricted stock units After the November 1, 2026 transaction

Key Terms

Restricted Stock Unit, vests in three equal annual installments, tax withholding obligations

3 terms

Restricted Stock Unit financial

"Each Restricted Stock Unit represents the contingent right to receive one share"

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

vests in three equal annual installments financial

"grant that vests in three equal annual installments beginning on November 1, 2025"

tax withholding obligations financial

"Stock withholding to satisfy tax withholding obligations"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did LH's EVP receive from vested RSUs?

Akinbolade Oyegunwa converted 370 vested restricted stock units into 370 common shares on November 1, 2026. The units came from a grant that vests in three equal annual installments beginning November 1, 2025.

How many LH shares were withheld for taxes, and at what price?

118 common shares were withheld on November 2, 2026, at $355.59 per share to satisfy tax withholding obligations. No Rule 10b5-1 plan is reported.

How many RSUs did the LH executive hold after the transaction?

The reported aggregate holding after the November 1, 2026 transaction was 2,570 restricted stock units.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Oyegunwa Akinbolade

(Last)

(First)

(Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON

NORTH CAROLINA

27215

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	EVP, CIO & CTO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
11/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	11/01/2026		M		370	A	⁽¹⁾	5,434.253	D
Common Stock	11/02/2026		F⁽²⁾		118	D	$355.59	5,316.253	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Unit	⁽¹⁾	11/01/2026		M			370	⁽³⁾	⁽³⁾	Common Stock	370	$0	2,570⁽⁴⁾	D

Explanation of Responses:

1. Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

2. Stock withholding to satisfy tax withholding obligations.

3. The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on November 1, 2025.

4. This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

	/s/ Kathryn W. Kyle, Attorney-in-Fact for Akinbolade Oyegunwa	11/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR